Ventyx Biosciences EBIT

Ventyx Biosciences (VTYX) currently reports a EBIT of $-120M as of September 2025. That compares with $-160M in the prior-year period — up 28.7% year over year. That is below the sector sector average of $-26M. Use the charts on this page to explore Ventyx Biosciences's EBIT history and peer comparisons.

Ventyx Biosciences's EBIT increased from $-160M to $-120M — a 28.7% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ventyx Biosciences's EBIT of $-120M is lower than the its sector sector average of $-26M. That is roughly 352.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Ventyx Biosciences reported $-120M in EBIT as of September 2025. That compares with $-160M in the prior-year period — up 28.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-120M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-26M. From there, open related valuation or income-statement pages for Ventyx Biosciences, and consider following VTYX for alerts when major investors trade the stock.